Cargando…
SUN-LB117 Faster Acting Insulin Aspart in Patients With Gestational Diabetes Mellitus - an Early Experience From India
Aims: This study was undertaken to assess the effectiveness and safety of faster acting insulin aspart in patients with gestational diabetes. Though faster acting insulin aspart is approved to be used in pregnancy by regulatory bodies like USFDA, EMA and DCGI (India), no data is published till date...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208662/ http://dx.doi.org/10.1210/jendso/bvaa046.2115 |